Navigation Links
Synthetic biology -- opportunities and risks
Date:8/3/2009

The new research field of synthetic biology will, in the medium term, open up a great deal of potential for combining novel genetic methods with engineering principles. This will facilitate the development, not only of new vaccines and medicines, but also of fuels and new materials. Early-stage dialogue with the public on the natural science, legal, economic and ethical issues is crucial for the success and acceptance of this new technology. With a joint position paper on the opportunities and risks posed by synthetic biology, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), acatech (the German Academy of Science and Engineering), and the German Academy of Scientists Leopoldina, the National Academy of Sciences, now want to initiate this dialogue.

The new statement was presented today by the Presidents of the three organisations, Professors Matthias Kleiner (DFG), Reinhard Httl (acatech) and Volker ter Meulen (Leopoldina), at a press conference in Berlin.

In four chapters totalling 40 pages, the research policy paper takes a stance on selected research fields, current challenges, and the safety and ethical issues raised by the forward-looking research field of synthetic biology.

In synthetic biology, two research approaches predominate: on the one hand, inanimate substances are used to construct "the building blocks of life". These are then combined to form a living organism. On the other, researchers attempt to remove components from natural organisms and replace them with others in order to create artificial life forms. These methods are based on the advances in gene technology, in particular the technical feasibility of increasingly rapidly decoding genetic information and re-synthesising it. In the medium term, the potential applications of synthetic biology range from medicine and environmental technology right through to biotechnology.

A group of experts led by Berlin-based microbiologist Professor Brbel Friedrich, a member of the DFG Senate Commission on Genetic Research and Vice President of the Leopoldina, developed the joint statement based on the findings of an international and interdisciplinary workshop held in Berlin on 27 February. The workshop brought together scientists and academics from the fields of biochemistry, molecular biology, genetics, microbiology, virology, chemistry, physics and the engineering sciences, as well as from the humanities and social sciences.

The statement was subsequently passed by the Executive Committees of the three organisations and defines five spheres of activity to outline how Germany can best profit from the potential offered by synthetic biology. These five spheres of activity are:

  • the strengthening of basic research
  • the bundling of relevant disciplines in research and education
  • the development of patenting processes
  • the elimination of threats and the prevention of misuse
  • the monitoring of this new research field using technology assessment methods

For the foreseeable future, the focus of synthetic biology will, in the opinion of the three organisations, lie in basic research. The paper comes to the conclusion that the success of synthetic biology will depend substantially on the extent to which it is able to bring together the wide variety of disciplines as early as the student training stage. Safety-relevant aspects are also addressed, with the paper concluding that, according to the current state of research, the existing laws aimed at ensuring biological safety (biosafety) and at eliminating potential misuse (biosecurity) are sufficient. Despite this, a continuous discussion on safety-relevant issues is considered necessary. This should, in the authors' opinion, be assigned to the Central Commission for Biological Safety (ZKBS).

The "Synthetic Biology" statement is directed particularly at politicians and interested members of the public.


'/>"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Related medicine news :

1. New Study Finds Yet Another Link to Cancer, Synthetic Hormones
2. CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)
3. Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage
4. Organic Left Standing as the Gold Standard for Consumers Looking to Avoid Food Produced With Synthetic Growth Hormones
5. QLT announces completion of Phase Ia safety trial of its synthetic retinoid product
6. Synthetic gene circuit allows precise dosing of gene expression
7. CPC Pursues Development of Proprietary Synthetic Sealants as part of MedClose(TM) Global Commercialization
8. Brookhaven Lab and BioSET patent a synthetic peptide that enhances bone growth
9. Synthetic HDL Could Fight Heart Disease
10. Synthetic HDL: A new weapon to fight cholesterol problems
11. New center launched today to spearhead UK research in synthetic biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: